Zeo ScientifiX (ZEOX) Share-based Compensation (2017 - 2026)
Zeo ScientifiX (ZEOX) posted quarterly Share-based Compensation of $590000.0 for Q2 2026, down 46.17% year-over-year from $1.1 million in Q2 2025, and down 47.42% quarter-over-quarter from $1.1 million in Q1 2026.
Zeo ScientifiX (ZEOX) Share-based Compensation (2017 - 2026) Analysis & Trends
Zeo ScientifiX's Share-based Compensation history runs 10 years deep, the most recent figure standing at $590000.0 for Q2 2026.
- In Q2 2026, Share-based Compensation fell 46.17% year-over-year to $590000.0; the TTM figure through Apr 2026 stood at $3.5 million (down 8.83% YoY), while the FY2025 annual figure was $4.7 million, up 21.8% from the prior year.
- Share-based Compensation for Q2 2026 stood at $590000.0, down from $1.1 million in the prior quarter.
- The five-year high for Share-based Compensation was $2.0 million in Q3 2022, with the low at $259592.0 in Q2 2022.
- The 5-year median for Share-based Compensation is $786000.0 (2023), against an average of $913724.3.
- Peak annual rise in Share-based Compensation reached 307.95% in 2022, while the deepest fall reached 92.02% in 2022.
- Zeo ScientifiX's Share-based Compensation stood at $1.1 million in 2022, then dropped by 27.73% to $799000.0 in 2023, then jumped by 37.92% to $1.1 million in 2024, then plunged by 31.4% to $756000.0 in 2025, then retreated by 21.96% to $590000.0 in 2026.
- Business Quant data shows ZEOX's Share-based Compensation at $590000.0 in Q2 2026, $1.1 million in Q1 2026, and $756000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 108.10 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 243.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 120.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 137.41 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 86.63 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 28.05 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 41.25 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Zeo ScientifiX | 10.51 Mn | 8.67 Mn | 2.06 Mn | 590,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 590,000.00 |
| Apr 30, 2026 | 590,000.00 |
| Jan 31, 2026 | 1.12 Mn |
| Jan 31, 2026 | 1.12 Mn |
| Oct 31, 2025 | 756,000.00 |
| Oct 31, 2025 | 756,000.00 |
| Jul 31, 2025 | 1.68 Mn |
| Jul 31, 2025 | 1.68 Mn |
| Apr 30, 2025 | 1.10 Mn |
| Apr 30, 2025 | 1.10 Mn |
| Jan 31, 2025 | 1.09 Mn |
| Jan 31, 2025 | 1.09 Mn |
| Oct 31, 2024 | 1.10 Mn |
| Oct 31, 2024 | 1.10 Mn |
| Jul 31, 2024 | 586,000.00 |
| Jul 31, 2024 | 586,000.00 |
| Apr 30, 2024 | 527,000.00 |
| Apr 30, 2024 | 527,000.00 |
| Jan 31, 2024 | 773,000.00 |
| Jan 31, 2024 | 773,000.00 |